Contineum Therapeutics (CTNM) Current Leases (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Current Leases of $2.4 million for Q2 2026, up 63.23% year-over-year from $1.5 million in Q2 2025, and up 3.91% quarter-over-quarter from $2.3 million in Q1 2026.
Contineum Therapeutics (CTNM) Current Leases (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $2.4 million for Q2 2026.
- In Q2 2026, Current Leases rose 63.23% year-over-year to $2.4 million; the TTM figure through Jun 2026 stood at $2.4 million (up 63.23% YoY), while the FY2025 annual figure was $2.3 million, up 61.23% from the prior year.
- Current Leases for Q2 2026 stood at $2.4 million, up from $2.3 million in the prior quarter.
- The five-year high for Current Leases was $2.4 million in Q2 2026, with the low at $464000.0 in Q4 2023.
- The 4-year median for Current Leases is $1.5 million (2025), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2026: Current Leases surged 212.93% in 2024, then surged 58.28% in 2026.
- Contineum Therapeutics' Current Leases stood at $464000.0 in 2023, then soared by 212.93% to $1.5 million in 2024, then surged by 61.23% to $2.3 million in 2025, then climbed by 2.22% to $2.4 million in 2026.
- Business Quant data shows CTNM's Current Leases at $2.4 million in Q2 2026, $2.3 million in Q1 2026, and $2.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | 474,000.00 |
| Dec 31, 2023 | 464,000.00 |